Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126626) titled 'Effect of subanesthetic dose of esketamine on postoperative rehabilitation in frailty patients undergoing hip arthroplasty' on June 12.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huai He Hospital of Henan University
Condition:
Femoral neck fracture
Intervention:
A group:esketamine
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2024-04-04
Target Sample Size: A group:63;B group:63;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300414
Published by HT Digital Content Services with permission from ...